#89, Accelerating Drug R&D, Part One of the Health Innovation Compilation Series
05/06/2024
0:00
55:13
Dive into the groundbreaking approaches of companies like VivoDyne, Seer, Ordaos, Insilico Medicine, and Alchemab, who are pushing boundaries in drug R&D through microfluidic bioengineering, proteome mapping, AI-driven drug design, and resilient antibody discovery.
Mais episódios de "AWS Health Innovation Podcast"
Não percas um episódio de “AWS Health Innovation Podcast” e subscrevê-lo na aplicação GetPodcast.